Health and Healthcare

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

577 Articles

Lee Jackson | May 25, 2017 at 10:15 AM EDT

Big Pharma Has Big Catalysts Coming for the Rest of 2017

A new Deutsche Bank research report focuses on the big capitalization pharmaceutical stocks and the upcoming catalysts and news flow…

Chris Lange | May 25, 2017 at 9:45 AM EDT

Major Pharma Short Interest Surges

The May 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Paul Ausick | May 15, 2017 at 11:35 AM EDT

Top Credit Suisse Pharma Picks Ahead of Catalysts

Credit Suisse provided its outlook for several large-cap pharmaceutical stocks Monday morning. The analyst has three top picks to consider.

Lee Jackson | May 12, 2017 at 8:25 AM EDT

Stock Market Looks Very Overbought: 5 Safe Stocks to Buy Now

Here are five good blue chip dividend stocks that are reasonably safe and offer good dividends, and they look good…

Trey Thoelcke | May 11, 2017 at 11:40 AM EDT

Why Big Pharma Is Not at Fault for Record Drug Spending

With prescription drug spending breaking new records almost every year now, people like to blame Big Pharma and use it…

Jon C. Ogg | May 11, 2017 at 11:00 AM EDT

Merck’s Accelerated Keytruda Lung Cancer Approval Creates 3 Moves

It is no secret that pharma and biotech shares have had to deal with at least some headwinds over the…

Chris Lange | May 10, 2017 at 9:00 AM EDT

Short Interest in Major Pharma Shrinks

The April 28 short interest data have been compared with the previous figures, and short interest moves in these selected…

Lee Jackson | May 5, 2017 at 8:20 AM EDT

JPMorgan Has 3 Top Pick Large Cap Pharmaceuticals to Buy for the Rest of 2017

JPMorgan has made the case that the best place for investors to look when considering large cap drug stocks is…

Chris Lange | Apr 26, 2017 at 11:30 AM EDT

AbbVie, Celgene and 2 More Major Biotechs Reporting Earnings Thursday

24/7 Wall St. has put together a preview of some of the world’s largest biotech and pharma companies reporting their…

Chris Lange | Apr 26, 2017 at 8:25 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Pharma

The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Lee Jackson | Apr 17, 2017 at 10:00 AM EDT

Top Dividend Pharmaceutical Stocks Safe Bet for Rest of 2017

With interest rates once again dropping as the geopolitical worries ratchet up, investors are concerned about owning good stocks and…

Chris Lange | Apr 12, 2017 at 8:25 AM EDT

Short Sellers Run for Cover From Major Pharma Stocks

The March 31 short interest data have been compared with the previous figures, and short interest decreased in most of…

Chris Lange | Mar 27, 2017 at 8:35 AM EDT

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

The March 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Mar 20, 2017 at 10:55 AM EDT

Monday’s Top Biopharma Movers

Esperion Therapeutics and a few other biopharma stocks made massive runs on Monday morning.

Chris Lange | Mar 10, 2017 at 8:55 AM EST

Short Sellers Back Off Major Pharma

The February 28 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 18 19 20 21 22 … 39

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Big Pharma Has Big Catalysts Coming for the Rest of 2017

Major Pharma Short Interest Surges

Top Credit Suisse Pharma Picks Ahead of Catalysts

Stock Market Looks Very Overbought: 5 Safe Stocks to Buy Now

Why Big Pharma Is Not at Fault for Record Drug Spending

Merck’s Accelerated Keytruda Lung Cancer Approval Creates 3 Moves

Short Interest in Major Pharma Shrinks

JPMorgan Has 3 Top Pick Large Cap Pharmaceuticals to Buy for the Rest of 2017

AbbVie, Celgene and 2 More Major Biotechs Reporting Earnings Thursday

Short Sellers Can’t Make Up Their Minds on Major Pharma

Top Dividend Pharmaceutical Stocks Safe Bet for Rest of 2017

Short Sellers Run for Cover From Major Pharma Stocks

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

Monday’s Top Biopharma Movers

Short Sellers Back Off Major Pharma

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Big Pharma Has Big Catalysts Coming for the Rest of 2017

Major Pharma Short Interest Surges

Top Credit Suisse Pharma Picks Ahead of Catalysts

Stock Market Looks Very Overbought: 5 Safe Stocks to Buy Now

Why Big Pharma Is Not at Fault for Record Drug Spending

Merck’s Accelerated Keytruda Lung Cancer Approval Creates 3 Moves

Short Interest in Major Pharma Shrinks

JPMorgan Has 3 Top Pick Large Cap Pharmaceuticals to Buy for the Rest of 2017

AbbVie, Celgene and 2 More Major Biotechs Reporting Earnings Thursday

Short Sellers Can’t Make Up Their Minds on Major Pharma

Top Dividend Pharmaceutical Stocks Safe Bet for Rest of 2017

Short Sellers Run for Cover From Major Pharma Stocks

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

Monday’s Top Biopharma Movers

Short Sellers Back Off Major Pharma

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%